Affinivax Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Affinivax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10966
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Affinivax Inc (Affinivax) is a biotechnology company that develops vaccines for infectious diseases. The company uses Multiple Antigen Presenting System technology to enable affinity binding of protective polysaccharides and proteins in a single vaccine. It develops vaccine programs for streptococcus pneumoniae, and bacterial nosocomial infections. Affinivax provide pipeline of vaccines for both children and adults. The company significant advance vaccine technologies to induce protective immune responses. The company works in collaboration with various pharmaceutical companies for the development of vaccines. Affinivax is headquartered in Lexington, Massachusetts, the US.

Affinivax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Affinivax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Affinivax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Affinivax Raises USD7 Million in Venture Financing 10
Affinivax Raises USD2.5 Million in Venture Financing 11
Affinivax Raises USD4 Million in Seed Venture Financing 12
Partnerships 13
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 13
Affinivax Enters into Development Agreement with PATH for Pneumococcal Disease 14
Licensing Agreements 15
Astellas Pharma Enters into Licensing Agreement with Affinivax 15
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 16
Affinivax Inc – Key Competitors 17
Affinivax Inc – Key Employees 18
Affinivax Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Affinivax Inc, Pharmaceuticals & Healthcare, Key Facts 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Affinivax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Affinivax Raises USD7 Million in Venture Financing 10
Affinivax Raises USD2.5 Million in Venture Financing 11
Affinivax Raises USD4 Million in Seed Venture Financing 12
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 13
Affinivax Enters into Development Agreement with PATH for Pneumococcal Disease 14
Astellas Pharma Enters into Licensing Agreement with Affinivax 15
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 16
Affinivax Inc, Key Competitors 17
Affinivax Inc, Key Employees 18

List of Figures
Affinivax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Affinivax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Affinivax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Affinivax Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AB Electrolux:企業の戦略・SWOT・財務情報
    AB Electrolux - Strategy, SWOT and Corporate Finance Report Summary AB Electrolux - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Foodstuffs South Island Ltd:戦略・SWOT・企業財務分析
    Foodstuffs South Island Ltd - Strategy, SWOT and Corporate Finance Report Summary Foodstuffs South Island Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Travere Therapeutics Inc (TVTX):企業の財務・戦略的SWOT分析
    Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BaroFold Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein herapeutics for bio-pharmaceutical companies, research institutions, and government agencies. The company applies its Pressure Enabled Protein Manufacturing (PreEMT) technology that improves the tolerability, efficacy a …
  • InviCRO LLC:医療機器:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Koito Manufacturing Co Ltd:企業の戦略・SWOT・財務情報
    Koito Manufacturing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koito Manufacturing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enel Americas S.A. (ENELAM):電力:M&Aディール及び事業提携情報
    Summary Enel Americas S.A. (Enel Americas), formerly Enersis Americas S.A., is an integrated electricity utility in Latin America. The group through its subsidiaries and affiliates carries out the generation, transmission and distribution of electricity in Argentina, Brazil, Colombia and Peru. Enel …
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • In’Tech Medical SAS:医療機器:M&Aディール及び事業提携情報
    Summary In'Tech Medical SAS (In'Tech Medical) is a medical device company that offers surgical equipment. The company designs, develops and manufactures orthopedic implants and instruments for the healthcare sector. Its surgical instruments include benders, calipers, cervical pin distractor, angled …
  • Impel NeuroPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 …
  • Costcutter Supermarkets Group Limited:企業の戦略・SWOT・財務情報
    Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Premier Gold Mines Limited:企業の戦略・SWOT・財務情報
    Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務分析
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sanquin Blood Supply Foundation-医療機器分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hutchison 3G UK Limited:企業の戦略・SWOT・財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆